Enteral vaccination of rats against Fasciola hepatica using recombinant cysteine proteinase (cathepsin L1)

Vaccine

Volumn 25, Issue 18, 2007, Pages 3619-3628

  Kesik, Małgorzata ^a   Jedlina Panasiuk, Luiza ^b   Kozak Cieszczyk, Monika ^b   Płucienniczak, Andrzej ^a   Wedrychowicz, Halina ^b,c  

^a INDUSTRIAL CHEMISTRY RESEARCH INSTITUTE   (Poland)

^b W STEFA SKI INSTITUTE OF PARASITOLOGY   (Poland)

^c WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Cysteine proteinase; Fasciola hepatica; Inclusion bodies; Oral vaccination

Indexed keywords

CATHEPSIN L 1; CYSTEINE PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL INCLUSION; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME SUBSTRATE; EOSINOPHIL; ESCHERICHIA COLI; FASCIOLIASIS; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MALE; METACERCARIA; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEAL CAVITY; PERITONEAL FLUID; PRIORITY JOURNAL; PROTECTION; RAT; STATISTICAL SIGNIFICANCE; TREMATODE; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; CATHEPSINS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; ESCHERICHIA COLI; FASCIOLA HEPATICA; FASCIOLIASIS; FEMALE; INCLUSION BODIES; MALE; PERITONEAL CAVITY; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; VACCINATION; VACCINES, SYNTHETIC;

EID: 34147109393     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.057     Document Type: Article

References (42)

1. We{ogonek}drychowicz H., and Wiśniewski M. Progress in development of vaccines against most important gastrointestinal helminth parasites of humans and animals. Acta Parasitol 48 (2003) 238-245
2. Vercruysse J., Knox D.P., Schetters T.P.M., and Willadsen P. Veterinary parasitic vaccines: pitfalls and future directions. Trends Parasitol 20 10 (2004) 488-492
3. Mas-Coma M.S., Esteban J.G., and Bargues M.D. Epidemiology of human fascioliasis: a review and proposed new classification. Bull World Health Organ 77 4 (1999) 340-346
4. Saba R., Korkmaz M., Inan D., Mamikoglu L., Turhan O., Gunseren F., et al. Human fascioliasis. Clin Microbiol Infect 10 5 (2004) 385-387
5. Fairweather I., and Boray J.C. Mechanisms of fasciolicide action and drug resistance in Fasciola hepatica. In: Dalton J.P. (Ed). Fascioliasis 1999 (1999), CAB International 225-276
6. Overend D.J., and Bowen F.L. Resistance of Fasciola hepatica to triclabendazole. Aust Vet J 72 7 (1995) 275-276
7. Mitchell G.B.B., Maris L., and Bonniwell M.A. Triclabendazole-resistant liver fluke in Scottish sheep. Vet Rec 143 14 (1998) 399
8. Moll L., Gaasenbeek C.P.H., Vellema P., and Borgsteede F.H.M. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in the Netherlands. Vet Parasitol 91 1-2 (2000) 153-158
9. Gaasenbeek C.P.H., Moll L., Cornelissen J.B.W.J., Vellema P., and Borgsteede F.H.M. An experimental study on triclabendazole resistance of Fasciola hepatica in sheep. Vet Parasitol 95 1 (2001) 37-43
10. Dalton J.P., Neill S.O., Stack C., Collins P., Walshe A., Sekiya M., et al. Fasciola hepatica cathepsin L-like proteases: biology, function, and potential in the development of first generation liver fluke vaccines. Int J Parasitol 33 11 (2003) 1173-1181
11. Walker R.I. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 12 5 (1994) 387-400
12. Spriggs M.K. One step ahead of the game: viral immunomodulatory molecules. Annu Rev Immunol 14 (1996) 101-130
13. van Milligen F.J., Cornelissen J.B.W.J., and Bokhout B.A. Fasciola hepatica: an antigen fraction derived from newly excysted juveniles, containing an immunoreactive 32-kDa protein, induces strong protective immunity in rats. Exp Parasitol 94 3 (2000) 163-171
14. We{ogonek}drychowicz H., Lamparska M., Ke{ogonek}sik M., Kotomski G., Mieszczanek J., Jedlina-Panasiuk L., et al. The immune response of rats to vaccination with the cDNA or protein forms of the cysteine proteinase of Fasciola hepatica. Vet Immunol Immunopathol 94 1-2 (2003) 83-93
15. Kofta W., Mieszczanek J., Płucienniczak G., and We{ogonek}drychowicz H. Successful DNA immunisation of rats against fasciolosis. Vaccine 18 26 (2000) 2985-2990
16. Mulcahy G., O'Neill S., Donnelly S., and Dalton J.P. Helminths at mucosal barriers-interaction with the immune system. Adv Drug Deliv Rev 56 6 (2004) 853-868
17. Smith S.M., and Gottesman M.M. Activity and deletion analysis of recombinant human cathepsin L expressed in Escherichia coli. J Biol Chem 264 34 (1989) 20487-20495
18. Dalton J.P., and Heffernan M. Thiol proteases released in vitro by Fasciola hepatica. Mol Biochem Parasitol 35 2 (1989) 161-166
19. Yamamoto Y., Watabe S., Kageyama T., and Takahashi S.Y. Proregion of Bombyx mori cysteine proteinase functions as an intramolecular chaperone to promote proper folding of the mature enzyme. Arch Insect Biochem Physiol 42 3 (1999) 167-178
20. Harness E., Doy T.G., and Hughes D.L. The early migratory behaviour of young Fasciola hepatica in sensitized mice. Int J Parasitol 7 1 (1977) 51-54
21. Tominaga T., Watanbe A., Tsuji J., Koda A., Nagai H., Kumazawa Y., et al. Effect of TYB-2285 on antigen-induced accumulation of eosinophils into the peritoneal cavity of rats sensitized with Ascaris suum extract. Gen Pharmacol 28 3 (1997) 411-414
22. Tliba O., Sibille P., Boulard C., and Chauvin A. Early hepatic cytokine mRNA expression in experimental rat fasciolosis. Vet Parasitol 103 3 (2002) 237-249
23. Abella N., Schelcher F., Delverdier M., Concordet D., Valarcher J.F., Espinasse J., et al. Flow cytometric analysis of bovine CD4 and CD8 lymphocytes: influence of blood sampling and processing methods. Res Vet Sci 57 2 (1994) 163-171
24. Manouvriez P., Lefebvre M., Genart C., Cormont F., and Bazin H. Accurate determination of rat immunoglobulin isotype content in culture supernatants or media by ELISA with mouse monoclonal antibodies. Immunobiology 173 (1986) 307-308
25. Mulcahy G., O'Connor F., McGonigle S., Dowd A., Clery D.G., Andrews S.J., et al. Correlation of specific antibody titre and avidity with protection in cattle immunized against Fasciola hepatica. Vaccine 16 9-10 (1998) 932-939
26. Mason R.W., Green G.D., and Barrett A.J. Human liver cathepsin L. Biochem J 226 1 (1985) 233-241
27. Barrett A.J., Kirschke H., Cathepsin B., Cathepsin H., and Cathepsin L. Methods Enzymol 80 (1981) 535-561
28. Dowd A.J., Tort J., Roche L., Ryan T., and Dalton J.P. Isolation of a cDNA encoding Fasciola hepatica cathepsin L2 and functional expression in Saccharomyces cerevisiae. Mol Biochem Parasitol 88 1-2 (1997) 163-174
29. Dowd A.J., Smith A.M., McGonigle S., and Dalton J.P. Purification and characterisation of a second cathepsin L proteinase secreted by the parasitic trematode Fasciola hepatica. Eur J Biochem 223 1 (1994) 91-98
30. Harmsen M.M., Cornelissen J.B.W.J., Buijs H.E., Boersma W.J., Jeurissen S.H., and van Milligen F.J. Identification of a novel Fasciola hepatica cathepsin L protease containing protective epitopes within the propeptide. Int J Parasitol 34 6 (2004) 675-682
31. Smooker P.M., Whisstock J.C., Irving J.A., Siyaguna S., Spithill T.W., and Pike R.N. A single amino acid substitution affects substrate specificity in cysteine proteinases from Fasciola hepatica. Protein Sci 9 12 (2000) 2567-2572
32. Mosmann T.R., and Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7 (1989) 145-173
33. Lawrence R.A., and Denham D.A. Stage and isotype specific immune responses in a rat model of filariasis. Parasite Immunol 15 8 (1993) 429-439
34. Poitou I., Baeza E., and Boulard C. Humoral and cellular immune responses in rats during a primary infestation with Fasciola hepatica. Vet Parasitol 45 1-2 (1992) 59-71
35. Keegan P.S., and Trudgett A. Fasciola hepatica in the rat: immune responses associated with the development of resistance to infection. Parasite Immunol 14 6 (1992) 657-669
36. Paz A., Sanchez-Andrade R., Panadero R., Suarez J.L., Diez-Banos P., and Morrondo P. Subclass profile of specific IgG antibodies in rats challenged during acute and chronic primary infection with Fasciola hepatica. Parasitol Res 85 8-9 (1999) 770-775
37. Lebens M., Sun J.B., Sadeghi H., Bäckström M., Olsson I., Mielcarek N., et al. A mucosally administered recombinant fusion protein vaccine against schistosomiasis protecting against immunopathology and infection. Vaccine 21 5-6 (2003) 514-520
38. McGuire C., Chan W.C., and Wakelin D. Nasal immunization with homogenate and peptide antigens induces protective immunity against Trichinella spiralis. Infect Immun 70 12 (2002) 7149-7152
39. Van Milligen F.J., Cornelissen J.B.W.J., Hendriks I.M., Gaasenbeek C.P.H., and Bokhout B.A. Protection of Fasciola hepatica in the gut mucosa of immune rats is associated with infiltrates of eosinophils, IgG1 and IgG2a antibodies around the parasites. Parasite Immunol 20 6 (1998) 285-292
40. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20 (2002) 197-216
41. Klion A.D., and Nutman T.B. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 113 1 (2004) 30-37
42. Sibille P., Tliba O., and Boulard C. Early and transient cytotoxic response of peritoneal cells from Fasciola hepatica-infected rats. Vet Res 35 5 (2004) 573-584